LEI 391200SUW7CVPRE6UD92
Robert Bosch Gesellschaft für medizinische Forschung mbH
Group parent: R o b e r t B o s c h S t i f t u n g Gesellschaft mit beschränkter Haftung
Contract awards & public grants
Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needS → ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH
European Commission · DE · Grant · 2023-12-08
€654,213
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement → ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH
European Commission · DE · Grant · 2019-03-22
€2.43M
conect4children (COllaborative Network for European Clinical Trials For Children) → ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH
European Commission · DE · Grant · 2018-06-22
€2.02M
Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen → ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH
European Commission · DE · Grant · 2015-12-09
€561,394
Early risk detection and prevention in ageing people by self-administered ICT-supported assessment and a behavioural change intervention delivered by → ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG MBH
European Commission · DE · Grant · 2015-11-10
€665,325
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.